157 related articles for article (PubMed ID: 15451412)
1. Specific GABA(A) circuits in brain development and therapy.
Möhler H; Fritschy JM; Crestani F; Hensch T; Rudolph U
Biochem Pharmacol; 2004 Oct; 68(8):1685-90. PubMed ID: 15451412
[TBL] [Abstract][Full Text] [Related]
2. GABA-based therapeutic approaches: GABAA receptor subtype functions.
Rudolph U; Möhler H
Curr Opin Pharmacol; 2006 Feb; 6(1):18-23. PubMed ID: 16376150
[TBL] [Abstract][Full Text] [Related]
3. Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptors.
Möhler H
J Neurochem; 2007 Jul; 102(1):1-12. PubMed ID: 17394533
[TBL] [Abstract][Full Text] [Related]
4. Role of GABAA receptors in cognition.
Möhler H
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1328-33. PubMed ID: 19909270
[TBL] [Abstract][Full Text] [Related]
5. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes.
Cooper SJ
Appetite; 2005 Apr; 44(2):133-50. PubMed ID: 15808888
[TBL] [Abstract][Full Text] [Related]
6. GABA(A) receptor diversity and pharmacology.
Möhler H
Cell Tissue Res; 2006 Nov; 326(2):505-16. PubMed ID: 16937111
[TBL] [Abstract][Full Text] [Related]
7. The GABAA receptor gene family: new opportunities for drug development.
Whiting PJ
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):648-57. PubMed ID: 14579514
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and pharmacology of GABA(A) receptors.
Möhler H; Fritschy JM; Vogt K; Crestani F; Rudolph U
Handb Exp Pharmacol; 2005; (169):225-47. PubMed ID: 16594261
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of GABAergic activity: neuropharmacological effects of benzodiazepines and therapeutic use in anesthesiology.
Saari TI; Uusi-Oukari M; Ahonen J; Olkkola KT
Pharmacol Rev; 2011 Mar; 63(1):243-67. PubMed ID: 21245208
[TBL] [Abstract][Full Text] [Related]
10. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
[TBL] [Abstract][Full Text] [Related]
11. The complexity of the GABAA receptor shapes unique pharmacological profiles.
D'Hulst C; Atack JR; Kooy RF
Drug Discov Today; 2009 Sep; 14(17-18):866-75. PubMed ID: 19576998
[TBL] [Abstract][Full Text] [Related]
12. [Omega benzodiazepine receptor subtypes and new ligands].
Michelini S; Belfiore S; Perugi G; Petracca A; Cassano GB
Clin Ter; 1991 Apr; 137(1):39-48. PubMed ID: 1675599
[TBL] [Abstract][Full Text] [Related]
13. GABA(A) receptor subtypes as targets for neuropsychiatric drug development.
Korpi ER; Sinkkonen ST
Pharmacol Ther; 2006 Jan; 109(1-2):12-32. PubMed ID: 15996746
[TBL] [Abstract][Full Text] [Related]
14. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists.
Zeilhofer HU; Möhler H; Di Lio A
Trends Pharmacol Sci; 2009 Aug; 30(8):397-402. PubMed ID: 19616317
[TBL] [Abstract][Full Text] [Related]
15. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines.
Reynolds DS
Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867
[TBL] [Abstract][Full Text] [Related]
16. The benzodiazepine receptor.
Bergman SA
Anesth Prog; 1986; 33(5):213-9. PubMed ID: 3022619
[TBL] [Abstract][Full Text] [Related]
17. K+ channel TASK-1 knockout mice show enhanced sensitivities to ataxic and hypnotic effects of GABA(A) receptor ligands.
Linden AM; Aller MI; Leppä E; Rosenberg PH; Wisden W; Korpi ER
J Pharmacol Exp Ther; 2008 Oct; 327(1):277-86. PubMed ID: 18660435
[TBL] [Abstract][Full Text] [Related]
18. The role of GABA(A) receptor subtypes as analgesic targets.
Mirza NR; Munro G
Drug News Perspect; 2010; 23(6):351-60. PubMed ID: 20697602
[TBL] [Abstract][Full Text] [Related]
19. Modulation of presynaptic beta3-containing GABAA receptors limits the immobilizing actions of GABAergic anesthetics.
Grasshoff C; Jurd R; Rudolph U; Antkowiak B
Mol Pharmacol; 2007 Sep; 72(3):780-7. PubMed ID: 17584992
[TBL] [Abstract][Full Text] [Related]
20. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
